{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:15:00Z","timestamp":1785838500921,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.clbc.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T07:54:02Z","timestamp":1739001242000},"page":"455-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study"],"prefix":"10.1016","volume":"25","author":[{"given":"Neslihan","family":"Cab\u0131o\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Karanl\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahit","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"T\u00fckenmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"\u0130\u011fci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf E.","family":"Aytin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"K\u00f6ksal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halime","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"Bademler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Uras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"D\u00fclgero\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enver","family":"\u00d6zkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selman","family":"Emiro\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"M\u00fcsl\u00fcmano\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atakan","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcldeniz Karadeniz","family":"\u00c7akmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Balbalo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"Zihni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahad\u0131r M.","family":"G\u00fcll\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.clbc.2025.02.002_bib0001","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.breast.2021.11.018","article-title":"De-escalating axillary surgery in early-stage breast cancer","volume":"62","author":"Hersh","year":"2022","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.clbc.2025.02.002_bib0002","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0003","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2025.02.002_bib0004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel lymph-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0006","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2025.02.002_bib0007","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.clbc.2025.02.002_bib0008","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2025.02.002_bib0009","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","article-title":"Eight-year follow up result of the OTOASOR trial: the optimal treatment of the axilla-surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial","volume":"43","author":"Savolt","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"13","key":"10.1016\/j.clbc.2025.02.002_bib0011","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.clbc.2025.02.002_bib0012","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/bjs\/znad215","volume":"110","author":"Tinterri","year":"2023","journal-title":"Br J Surgery"},{"issue":"4","key":"10.1016\/j.clbc.2025.02.002_bib0013","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clbc.2024.03.004","article-title":"Systemic therapy advances for HER2-positive and triple negative breast cancer: what the surgeon needs to know","volume":"24","author":"Downs-Canner","year":"2024","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2025.02.002_bib0014","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/cncr.34750","article-title":"Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts","volume":"129","author":"Weiss","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2025.02.002_bib0015","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1245\/s10434-016-5246-8","article-title":"How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study","volume":"23","author":"Mamtani","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(11)70336-9","article-title":"Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial","volume":"13","author":"Gianni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0017","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clbc.2025.02.002_bib0018","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab Emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.clbc.2025.02.002_bib0019","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clbc.2025.02.002_bib0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/tbj.14226","article-title":"Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers","volume":"27","author":"Weiss","year":"2021","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.clbc.2025.02.002_bib0021","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1245\/s10434-021-10812-6","article-title":"The attitudes of Brazilian breast surgeons on axillary management in early breast cancer-10 years after the ACOSOG Z0011 trial first publication","volume":"29","author":"Millen","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2025.02.002_bib0022","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1245\/s10434-014-4090-y","article-title":"Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery","volume":"22","author":"Chung","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2025.02.002_bib0023","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1245\/s10434-016-5259-3","article-title":"Age and receptor status do not indicate the need for axillary dissection in patients with sentinel lymph node metastases","volume":"23","author":"Mamtani","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-023-03656-w","article-title":"Standardized pathology report for HER2 testing in compliance with 2023 ASCO\/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer","volume":"484","author":"Ivanova","year":"2024","journal-title":"Virchows Archiv"},{"issue":"12","key":"10.1016\/j.clbc.2025.02.002_bib0025","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1245\/s10434-014-3851-y","article-title":"Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement","volume":"21","author":"Ugras","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2025.02.002_bib0026","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1245\/s10434-017-6075-0","article-title":"Patient age and tumor subtype predict the extent of axillary surgery among breast cancer patients eligible for the American College of Surgeons Oncology Group Trial Z0011","volume":"24","author":"Ong","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2025.02.002_bib0027","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1245\/s10434-019-08104-1","article-title":"Microscopic extracapsular extension in sentinel lymph nodes does not mandate axillary dissection in Z0011-eligible patients","volume":"27","author":"Barrio","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2025.02.002_bib0028","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1200\/JCO.23.01009","article-title":"Pathologic exploration of the axillary soft tissue microenvironment and its impact on axillary management and breast cancer outcomes","volume":"42","author":"Naoum","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0029","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2025.02.002_bib0030","article-title":"on behalf of the SENOMAC Trialists\u2019 Group. Quality assessment of radiotherapy in the prospective randomized SENOMAC trial","volume":"197","author":"Alknera","year":"2024","journal-title":"Radiotherapy Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2025.02.002_bib0031","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer. MA.20 study investigators","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clbc.2025.02.002_bib0032","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092500031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092500031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:15:10Z","timestamp":1750148110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682092500031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S152682092500031X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2025.02.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}